Reliability and Validity of the Turkish Adaptation of VITACORA-19 in Patients With Psoriatic Arthritis

Terzi, Yuksel; ZAHİROĞLU, Yeliz; farisoğulları, bayram; KESMEN, Hakan; ulus, yasemin; Kuru, Omer; AKYOL, Yeşim; TANDER, NAZİFE BERNA; BİLGİCİ, Ayhan

Reliability and Validity of the Turkish Adaptation of VITACORA-19 in Patients With Psoriatic Arthritis

NAZİFE BERNA TANDER, (Ondokuz Mayıs Üniversitesi, Tıp Fakültesi, Fiziksel Tıp ve Rehabilitasyon Anabilim Dalı, Samsun, Türkiye)

Yasemin ULUS, (Ondokuz Mayıs Üniversitesi, Tıp Fakültesi, Fiziksel Tıp ve Rehabilitasyon Anabilim Dalı, Samsun, Türkiye)

Yüksel TERZİ, (Ondokuz Mayıs Üniversitesi, Fen Edebiyat Fakültesi, İstatistik Bölümü, Samsun, Türkiye)

Yeliz ZAHİROĞLU, (Ondokuz Mayıs Üniversitesi, Tıp Fakültesi, Fiziksel Tıp ve Rehabilitasyon Anabilim Dalı, Samsun, Türkiye)

Hakan KESMEN, (Ondokuz Mayıs Üniversitesi, Tıp Fakültesi, Fiziksel Tıp ve Rehabilitasyon Anabilim Dalı, Samsun, Türkiye)

Bayram FARİSOĞULLARI, (Ondokuz Mayıs Üniversitesi, Tıp Fakültesi, Fiziksel Tıp ve Rehabilitasyon Anabilim Dalı, Samsun, Türkiye)

Yeşim AKYOL, (Ondokuz Mayıs Üniversitesi, Tıp Fakültesi, Fiziksel Tıp ve Rehabilitasyon Anabilim Dalı, Samsun, Türkiye)

Ayhan BİLGİCİ, (Ondokuz Mayıs Üniversitesi, Tıp Fakültesi, Fiziksel Tıp ve Rehabilitasyon Anabilim Dalı, Samsun, Türkiye)

Ömer KURU (Ondokuz Mayıs Üniversitesi, Tıp Fakültesi, Fiziksel Tıp ve Rehabilitasyon Anabilim Dalı, Samsun, Türkiye)

Archives of Rheumatology

6 0

Yıl: 2016 Cilt: 31 Sayı: 4 Sayfa Aralığı: 321 - 328 Metin Dili: İngilizce İndeks Tarihi: 29-07-2022

Reliability and Validity of the Turkish Adaptation of VITACORA-19 in Patients With Psoriatic Arthritis

Öz:

Objectives: This study aims to evaluate the reliability and validity of the Turkish language version of VITACORA-19 (psoriatic arthritis quality of life questionnaire) in patients with psoriatic arthritis.Patients and methods: The Turkish version of VITACORA-19 questionnaire was obtained after a translation and back translation process. The study sample included 61 PsA patients (22 males, 39 females; mean age 46.5±12.2 years; range 19 to 71 years). To assess the test-retest reliability of the Turkish VITACORA-19, the questionnaire was reapplied 10 to 15 days after the first interview (interclass correlation coefficient). Cronbach's alpha (a) was used to evaluate the internal consistency. VITACORA-19 was compared with visual analog scale for physician and patient global assessments, the Health Assessment Questionnaire, and Nottingham Health Profile for construct validity. The internal structure of VITACORA-19 was examined by factor analysis.Results: The individual item intraclass correlation coefficient ranged from 0.77 to 0.98 and Cronbach's alpha ranged from 0.77 to 0.98. The Cronbach's alpha value for whole scale was determined as 0.96. The Kaiser-Meyer-Olkin measure of sampling adequacy was 0.90, and Bartlett's test of sphericity had a p<0.001. Turkish VITACORA-19 total scores were correlated negatively with Health Assessment Questionnaire, visual analog scale for pain, and Nottingham Health Profile subgroups, and positively with physician and patient global assessments (p<0.01).Conclusion: Turkish version of VITACORA-19 questionnaire is a reliable and valid measure for health-related quality of life in Turkish patients with psoriatic arthritis.

Anahtar Kelime:

Konular: Romatoloji

Belge Türü: Makale Makale Türü: Araştırma Makalesi Erişim Türü: Erişime Açık

Duarte GV, Faillace C, Freire de Carvalho J. Psoriatic arthritis. Best Pract Res Clin Rheumatol 2012;26:147
Gladman DD, Antoni C, Mease P, Clegg DO, Nash P. Psoriatic arthritis: epidemiology, clinical features, course, and outcome. Ann Rheum Dis 2005;64:14-7.
Dönmez S, Pamuk ÖN, Akker M, Ak R. Clinical features and types of articular involvement in patients with psoriatic arthritis. Clin Rheumatol 2015;34:1091-6.
Lee S, Mendelsohn A, Sarnes E. The burden of psoriatic arthritis: a literature review from a global health systems perspective. P T 2010;35:680-9.
Edson-Heredia E, Zhu B, Guo J, Maeda-Chubachi T, Lebwohl M. Disease burden and quality of life in psoriasis patients with and without comorbid psoriatic arthritis: results from National Psoriasis Foundation panel surveys. Cutis 2015;95:173-8.
Wilson IB, Cleary PD. Linking clinical variables with health-related quality of life. A conceptual model of patient outcomes. JAMA 1995;273:59-65.
Stucki G, Boonen A, Tugwell P, Cieza A, Boers M. The World Health Organisation International Classification of Functioning, Disability and Health: a conceptual model and interface for the OMERACT process. J Rheumatol ;34:600-6.
Cieza A, Stucki G. Content comparison of health- related quality of life (HRQOL) instruments based on the international classification of functioning, disability and health (ICF). Qual Life Res 2005;14:1225-37.
Laas K, Roine R, Räsänen P, Sintonen H, Leirisalo-Repo M. Health-related quality of life in patients with common rheumatic diseases referred to a university clinic. Rheumatol Int 2009;29:267-73.
Husted JA, Gladman DD, Farewell VT, Long JA, Cook RJ. Validating the SF-36 health survey questionnaire in patients with psoriatic arthritis. J Rheumatol 1997;24:511-7.
Zachariae H, Zachariae R, Blomqvist K, Davidsson S, Molin L, Mİrk C, et al. Quality of life and prevalence of arthritis reported by 5,795 members of the Nordic Psoriasis Associations. Data from the Nordic Quality of Life Study. Acta Derm Venereol 2002;82:108-13.
Rosen CF, Mussani F, Chandran V, Eder L, Thavaneswaran A, Gladman DD. Patients with psoriatic arthritis have worse quality of life than those with psoriasis alone. Rheumatology (Oxford) 2012;51:571-6.
McKenna SP, Doward LC, Whalley D, Tennant A, Emery P, Veale DJ. Development of the PsAQoL: a quality of life instrument specific to psoriatic arthritis. Ann Rheum Dis ;63:162-9.
Duruoz MT, Nas K, Ozgocmen S, Cerrahoglu L, Cevik R, Kosan U, et al. Translation and validation of the Turkish version of the psoriatic arthritis quality of life questionnaire (PSAQOL). Ann Rheum Dis 2010;69:699.
Healy PJ, Helliwell PS. Psoriatic arthritis quality of life instrument: an assessment of sensitivity and response to change. J Rheumatol 2008;35:1359-61.
Brodszky V, Péntek M, Bálint PV, Géher P, Hajdu O, Hodinka L, et al. Comparison of the Psoriatic Arthritis Quality of Life (PsAQoL) questionnaire, the functional status (HAQ) and utility (EQ-5D) measures in psoriatic arthritis: results from a cross-sectional survey. Scand J Rheumatol 2010;39:303-9.
Tezel N, Yilmaz Tasdelen O, Bodur H, Gul U, Kulcu Cakmak S, Oguz ID, et al. Is the health-related quality of life and functional status of patients with psoriatic arthritis worse than that of patients with psoriasis alone? Int J Rheum Dis 2015;18:63-9.
Wink F, Arends S, McKenna SP, Houtman PM, Brouwer E, Spoorenberg A. Validity and reliability of the Dutch adaptation of the Psoriatic Arthritis Quality of Life (PsAQoL) Questionnaire. PLoS One 2013;8:55912.
Billing E, McKenna SP, Staun M, Lindqvist U. Adaptation of the Psoriatic Arthritis Quality of Life (PsAQoL) instrument for Sweden. Scand J Rheumatol 2010;39:223-8.
Torre-Alonso JC, Gratacós J, Rey-Rey JS, Valdazo de Diego JP, Urriticoechea-Arana A, Daudén E, et al. Development and validation of a new instrument to measure health- related quality of life in patients with psoriatic arthritis: the VITACORA-19. J Rheumatol 2014;41:2008-17.
Taylor W, Gladman D, Helliwell P, Marchesoni A, Mease P, Mielants H. Classification criteria for psoriatic arthritis: development of new criteria from a large international study. Arthritis Rheum 2006;54:2665-73.
Hunt SM, McKenna SP, McEwen J, Williams J, Papp E. The Nottingham Health Profile: subjective health status and medical consultations. Soc Sci Med A 1981;15:221-9.
Kücükdeveci AA, McKenna SP, Kutlay S, Gürsel Y, Whalley D, Arasil T. The development and psychometric assessment of the Turkish version of the Nottingham Health Profile. Int J Rehabil Res 2000;23:31-8.
Bruce B, Fries JF. The Health Assessment Questionnaire (HAQ). Clin Exp Rheumatol 2005;23:14-8.
Küçükdeveci AA, Sahin H, Ataman S, Griffiths B, Tennant A. Issues in cross-cultural validity: example from the adaptation, reliability, and validity testing of a Turkish version of the Stanford Health Assessment Questionnaire. Arthritis Rheum 2004;51:14-9.
Gladman DD, Mease PJ, Strand V, Healy P, Helliwell PS, Fitzgerald O, et al. Consensus on a core set of domains for psoriatic arthritis. J Rheumatol 2007;34:1167-70.
Gratacós J, Daudén E, Gómez-Reino J, Moreno JC, Casado MÁ, Rodríguez-Valverde V. Health-related quality of life in psoriatic arthritis patients in Spain. Reumatol Clin 2014; :25-31.
Streiner DL, Norman GR. Health measurement scales. New York: Oxford University Press; 1989.
Fleiss JL, Shrout PE. The effects of measurement errors on some multivariate procedures. Am J Public Health ;67:1188-91.
DeCoster J. Overview of Factor Analysis. 1998. Available from: http://www.stathelp.com/notes.html Appendix

APA	TANDER N, ulus y, Terzi Y, ZAHİROĞLU Y, KESMEN H, farisoğulları b, AKYOL Y, BİLGİCİ A, Kuru O (2016). Reliability and Validity of the Turkish Adaptation of VITACORA-19 in Patients With Psoriatic Arthritis. , 321 - 328.
Chicago	TANDER NAZİFE BERNA,ulus yasemin,Terzi Yuksel,ZAHİROĞLU Yeliz,KESMEN Hakan,farisoğulları bayram,AKYOL Yeşim,BİLGİCİ Ayhan,Kuru Omer Reliability and Validity of the Turkish Adaptation of VITACORA-19 in Patients With Psoriatic Arthritis. (2016): 321 - 328.
MLA	TANDER NAZİFE BERNA,ulus yasemin,Terzi Yuksel,ZAHİROĞLU Yeliz,KESMEN Hakan,farisoğulları bayram,AKYOL Yeşim,BİLGİCİ Ayhan,Kuru Omer Reliability and Validity of the Turkish Adaptation of VITACORA-19 in Patients With Psoriatic Arthritis. , 2016, ss.321 - 328.
AMA	TANDER N,ulus y,Terzi Y,ZAHİROĞLU Y,KESMEN H,farisoğulları b,AKYOL Y,BİLGİCİ A,Kuru O Reliability and Validity of the Turkish Adaptation of VITACORA-19 in Patients With Psoriatic Arthritis. . 2016; 321 - 328.
Vancouver	TANDER N,ulus y,Terzi Y,ZAHİROĞLU Y,KESMEN H,farisoğulları b,AKYOL Y,BİLGİCİ A,Kuru O Reliability and Validity of the Turkish Adaptation of VITACORA-19 in Patients With Psoriatic Arthritis. . 2016; 321 - 328.
IEEE	TANDER N,ulus y,Terzi Y,ZAHİROĞLU Y,KESMEN H,farisoğulları b,AKYOL Y,BİLGİCİ A,Kuru O "Reliability and Validity of the Turkish Adaptation of VITACORA-19 in Patients With Psoriatic Arthritis." , ss.321 - 328, 2016.
ISNAD	TANDER, NAZİFE BERNA vd. "Reliability and Validity of the Turkish Adaptation of VITACORA-19 in Patients With Psoriatic Arthritis". (2016), 321-328.

APA	TANDER N, ulus y, Terzi Y, ZAHİROĞLU Y, KESMEN H, farisoğulları b, AKYOL Y, BİLGİCİ A, Kuru O (2016). Reliability and Validity of the Turkish Adaptation of VITACORA-19 in Patients With Psoriatic Arthritis. Archives of Rheumatology, 31(4), 321 - 328.
Chicago	TANDER NAZİFE BERNA,ulus yasemin,Terzi Yuksel,ZAHİROĞLU Yeliz,KESMEN Hakan,farisoğulları bayram,AKYOL Yeşim,BİLGİCİ Ayhan,Kuru Omer Reliability and Validity of the Turkish Adaptation of VITACORA-19 in Patients With Psoriatic Arthritis. Archives of Rheumatology 31, no.4 (2016): 321 - 328.
MLA	TANDER NAZİFE BERNA,ulus yasemin,Terzi Yuksel,ZAHİROĞLU Yeliz,KESMEN Hakan,farisoğulları bayram,AKYOL Yeşim,BİLGİCİ Ayhan,Kuru Omer Reliability and Validity of the Turkish Adaptation of VITACORA-19 in Patients With Psoriatic Arthritis. Archives of Rheumatology, vol.31, no.4, 2016, ss.321 - 328.
AMA	TANDER N,ulus y,Terzi Y,ZAHİROĞLU Y,KESMEN H,farisoğulları b,AKYOL Y,BİLGİCİ A,Kuru O Reliability and Validity of the Turkish Adaptation of VITACORA-19 in Patients With Psoriatic Arthritis. Archives of Rheumatology. 2016; 31(4): 321 - 328.
Vancouver	TANDER N,ulus y,Terzi Y,ZAHİROĞLU Y,KESMEN H,farisoğulları b,AKYOL Y,BİLGİCİ A,Kuru O Reliability and Validity of the Turkish Adaptation of VITACORA-19 in Patients With Psoriatic Arthritis. Archives of Rheumatology. 2016; 31(4): 321 - 328.
IEEE	TANDER N,ulus y,Terzi Y,ZAHİROĞLU Y,KESMEN H,farisoğulları b,AKYOL Y,BİLGİCİ A,Kuru O "Reliability and Validity of the Turkish Adaptation of VITACORA-19 in Patients With Psoriatic Arthritis." Archives of Rheumatology, 31, ss.321 - 328, 2016.
ISNAD	TANDER, NAZİFE BERNA vd. "Reliability and Validity of the Turkish Adaptation of VITACORA-19 in Patients With Psoriatic Arthritis". Archives of Rheumatology 31/4 (2016), 321-328.